Introduction
Pyrimidines and heterocyclic annulated pyrimidines exhibit interesting biological activities as medicinal applications [1] [2] [3] . A variety of anticancer drugs made from pyrimidine derivatives have clinical use currently, the hydrazinopyrimidine-Scarbonitrile derivatives have antineoplastic activities [4] . Moreover, pyrimidines and condensed pyrimidines are important classes of heterocyclic compounds that exhibit broad spectrum of biological activities such as anticancer [5, 6] , antiinflammatory, anti -allergic and analgesic activity [7] [8] [9] . In continuation of our efforts in this direction, we synthesized some new pyrimidine derivatives and condensed pyrimidine derivatives for biological evaluations.
Experimental

Instrumentation
Melting points are all uncorrected. The IR spectra (KBr) discs were recorded on a Perkin-Elmer 1650 spectrometer. 1 H NMR spectra was determined on Bruker Ac-300 MHz instrument. Chemical shifts are expressed as  (ppm) relative to tetramethylsilane (TMS) as internal standard and DMSO-d6 as solvent. The elemental analysis was carried by the Microanalytical center, Cairo University.
Synthesis
Ethyl 2-(4-chlorophenyl) 1-4-mercapto-6-phenyl pyrimidine-5-carboxylate (4)
A solution of p-chlorobenzoylthiocyanate (3) (0.01 mol) (prepared by refluxing p-chlorobenzoyl chloride (0.01 mol) and ammonium isothiocyanate (0.01 mol) in dry acetone (20 mL) for 2 h.) was added to ethyl-3-amino-3-phenylacrylate (0.01 mol) (prepared by bubbling ammonia gas into ethylbenzoyl acetate (0.01 mol) for 3 h at room temperature) in dry acetone. The reaction mixture was refluxed for 4 h filtered off and cooled. The solid obtained was filtered off, dried and recrystallized from ethanol 95% to give yellow crystals, 4 (Scheme 1 
2-(Acetoxymethyl)-6-(2-(4-chlorophenyl)-5-(ethoxy carbonyl)-6-phenylpyrimidin-4-ylthio)tetrahydro-2H-pyran-3,4,5-triyl triacetate (5)
A solution of compound 4 (0.01 mol) in aqueous potassium hydroxide (0.01 mol) in distilled water (10 mL) was added to a solution of 2,3,4,6-tetra-o-acetyl--D-glucopyranosyl bromide (0.01 mol) in acetone (30 mL). The reaction mixture was stirred for 4 h at room temperature. The mixture was evaporated under reduced pressure and the residue was washed with distilled water to remove the potassium bromide formed. The solid product was dried and recrystallized from ethanol affording pale gray crystals (Scheme 1 A mixture of compound 5 (0.01 mol) in methanol (30 mL), 1 mL of triethylamine (TEA) and few drops of water were stirred overnight at room temperature, the solvent was then removed under vacum, and the residue was washed with chloroform. The remaining residue was recrystallized from ethanol giving gray crystals (Scheme 1 
Synthesis of compounds 7a-d
A mixture of compound 4 (0.01 mol) and appropriate alkylating agent (benzyl chloride, ethyl bromoacetate, chloroacetamide and phenacyl bromide) and triethylamine (3 drops) in ethanol was refluxed for 30 min. The precipitate obtained upon cooling and dilution with water was collected and crystallized from suitable solvent (Scheme 2). 
Ethyl 4-(benzylthio)-2-(4chlorophenyl)-6-phenyl pyrimidine-5-carboxylate
Synthesis of compounds 8a-d
A mixture of appropriate pyrimidine (7a-d) (0.01 mol) and sodium ethoxide (0.01 mol) in ethanol (30 mL) was heated under reflux for 30 min. The precipitate formed after cooling and acidification with hydrochloric acid (3 mL, 60%) was collected and crystallized from suitable solvent (Scheme 2). 
Scheme 2
2-(4-Chlorophenyl)-4,6-diphenylthieno [2,3-d] pyrimidin-5-ol
6-(4-Chlorophenyl)-3-hydroxy-4-phenylthieno[2,3-d] pyrimidine dioxide (9)
Potassium permanganate (0.01 mol) was added in portions to a solution of compound 7b (0.01 mol) in chloroform (20 mL) and concentrated H2SO4 (1 mL) [10] . The reaction mixture was left at room temperature overnight, then ethanol (10 mL) was added and filtered off. The precipitate obtained was collected by filtration, dried and recrystallized from ethanol yield a colorless crystals (Scheme 2 
6-(4-Chlorophenyl)-4-(cyanomethylthio)-6-phenyl pyrimidine-5-carboxylate (11)
A mixture of compound 10 (0.01 mol) and hydrazine hydrate (0.01 mol) in n-butanol (20 mL) was refluxed for 2 h. The precipitate obtained upon cooling was collected and crystallized from butanol to give colorless crystal (Scheme 2 
Diethyl 6,6'-disulfanediyl bis(2-(4-chlorophenyl)-4-phenylpyrimidine-5-carboxylate (12)
Iodine (0.01 mol) was added to a suspension solution of compound 4 (0.01 mol) in acetic acid (20 mL) and stirred for 4 h. The white solid that obtained was filtered off and recrystallized from benzene afforded a colourless crystals (Scheme 2). Yield: 52%. M. 
2'-(4-Chlorophenyl)-4'-phenyl-2H,5'H-spiro[furan-3,6'-thieno[2,3-d] pyrimidine]-2,5,5'(4H)-trione (13)
A mixture of compound 4 (0.01 mol), maleic anhydride (0.01 mol) and few drops of piperidine (PIP) in (20 mL) xylene was refluxed for 16 h. The solid product that obtained after cooling was collected by filtration, dried and recrystallized from toluene to afford pale gray crystals (Scheme 2 
Ethyl 4-chloro-2-(4-chlorophenyl)-6-phenyl pyridimine-5-carboxylate (15)
Chlorine gas was bubbled through a suspension of compound 4 (0.01 mol) in acetic acid (20 mL, 25%) for about 4 h [11] . The resulting product was collected by filtration, washed with water, dried and recrystallized from benzene as a colorless crystal (Scheme 3 
Ethyl 5-(4-chlorophenyl)-7-phenyltetrazolo [1,5-c] pyrimidine-8-carboxylate (20)
A mixture of compound 15 (0.01 mol) and sodium azide (0.01 mol) in ethanol (30 mL) was refluxed for 4 h. The solid that separated after cooling and pouring into water was collected by filtration and crystallized from ethanol to give yellow crystals (Scheme 3). Yield: 60%. M. 
Results and discussion
The present work involves the synthesis of some new pyrimidine and condensed pyrimidine derivatives. Ethyl 2-(4-chlorophenyl)1-4-mercapto-6-phenylpyrimidine-5-carboxylate (4) which was readily synthesized by the interaction of isothiocyanate (2) with unsaturated amino ester (1) presumably via the non-isolable acyclic compound 3 that undergo intramolecular cyclodehydration affording the ethyl 2-(4-chlorophenyl)1-4-mercapto-6-phenylpyrimidine-5-carboxylate (4) (Scheme 1).
In an attempt to prepare nucleoside derivatives from the reaction of ethyl 2-(4-chlorophenyl)1-4-mercapto-6-phenylpyrimidine-5-carboxylate (4) and 2,3,4,6-tetra-O-acetyl-α-D-glycopyranosyl bromide in the presence of aqueous potassium hydroxide led to the formation of S-glycosyl derivative 5. The formation of compound 5 is proved by the disappearance of ν(SH) in IR spectra and appearance of signals at δ 1.87, 1.92, 1.95, 2.02 ppm due to the four methyl of the acetyl groups . Hydrolysis of compound 5 using triethylamine in methanol afforded the deacylated compound 6 which showed in IR spectra the disappearance of the acetyl groups and appearance of bands at 3420-3395 cm -1 for resulting of free hydroxyl groups.
The synthetic strategy toward thienopyrimidine is based on bulding a thiophene ring into a pyrimidine ring with two ortho substituents one electrophilic (C=O) and one potentially nucleophilic (SH) by its reaction with halomethylene to form a thiophene ring with appropriate functionalities. This result is usually achieved in one operation by a series of constitutive reactions, alkylation followed by ring closure at the electrophilic center and subsequent aromatization (8a-d).
Thus, when ethyl 2-(4-chlorophenyl) 1-4-mercapto-6-phenylpyrimidine-5-carboxylate (4) was allowed to react with activated halomethylene compounds (benzyl chloride, ethyl bromoacetate, chloroacetamide and/or phenacyl bromide) afforded the corresponding 4-alkylthiopyrimidine derivatives (7a-d) which converted to thienopyrimidine (8a-d) upon refluxing in basic medium.
Oxidative cyclization of compound 7b using potassium permengenate in acidic medium afforded thienopyrimidine dioxide (9) . While, alkylation of ethyl 2-(4-chlorophenyl) 1-4-mercapto-6-phenylpyrimidine-5-carboxylate (4) with acrylonitrile in pyrimidine afforded 4-cyanoethylmercapto pyrimidine derivative (10) which proved its structure by reaction with hydrazine hydrate [12] giving pyrazolopyrimidine (11) .The IR spectra of compound 11 showed the disappearance of the (C=O) group and the (CN) group. 1 H NMR of compound 11 showed a signal at  6.41 ppm characterized for NH group of pyrazole ring. Oxidation of ethyl 2-(4-chlorophenyl) 1-4-mercapto-6-phenylpyrimidine-5-carboxylate (4) using iodine in acetic acid [13] gives disulphide (12) . Spiro compound 13 was also obtained by addition of compound 4 to maleic anhydride in refluxing xylene and few drops of piperdine (Scheme 2).
Reaction of compound 4 with chlorine gas in acetic acid [14, 15] gave chloropyrimidine (15) . The conversion of compound 4 into compound 15 may be proceed through the formation of pyrimidine-4-sulphonyl chloride (14) which liberated sulfurdioxide to give compound 15 which reacted with thiourea affording the pyrimidopyrimidine (16) , while the condensation of compound 15 with benzilmonohydrazone gave the corresponding pyrimidopyridazine (18) via the initial formation of non-isolated open form (17) that underwent intramolecular cyclocondensation [16] [17] [18] . The reaction of compound 15 with sodium azide gave the corresponding tetrazolopyrimidine (20) presumably via the formation of azide form (19). The structure of compound 20 was proved by the disappearance of azido group in IR spectrum (Scheme 3).
Finally, synthesis of 6-(4-chlorophenyl)-4-phenyl-2-(1-phenylvinyl)-1H-pyrazolo [3,4-d] pyrimidine-3(2H)-one (21) was achieved by refluxing chloropyrimidine (15) with acetophenonehydrazone in ethanol in the presence of TEA (Scheme 4). The reaction may be proceeding via the formation of acyclic intermediate, followed by Ene-rearrangement then ring cyclization as shown in the following mechanism.
